Proteomic differences between focal and diffuse traumatic brain injury in human brain tissue

Area of Science:

• Neuroscience
• Biochemistry
• Proteomics

Background:

• Severe traumatic brain injury (TBI) is a complex condition with significant molecular consequences.
• Understanding the early molecular response is crucial for developing targeted therapies.
• Previous studies have not fully elucidated the molecular heterogeneity within TBI subtypes.

Purpose of the Study:

• To evaluate the early molecular response in structurally normal-appearing cortex following severe TBI.
• To compare the proteomic profiles of TBI patients with those of idiopathic normal pressure hydrocephalus patients.
• To investigate molecular differences between diffuse and focal TBI subtypes.

Main Methods:

• Analysis of cortical biopsies from 16 severe TBI patients and 11 idiopathic normal pressure hydrocephalus patients.
• Quantitative proteomics using mass spectrometry (label-free and stable isotope dimethyl labeling).
• Comparison of peptide expression levels related to neurodegeneration, antioxidant defense, and potential biomarkers.

Main Results:

• Distinct molecular patterns were observed in TBI patients compared to controls.
• Diffuse TBI showed increased expression of neurodegeneration peptides (Tau, Fascin) and potential biomarkers (Neurogranin, Fatty acid-binding protein).
• Diffuse TBI exhibited reduced expression of antioxidant defense peptides (Glutathione S-transferase Mu 3, Peroxiredoxin-6, Thioredoxin-dependent peroxide reductase).

Conclusions:

• Human brain biopsies reveal considerable molecular heterogeneity among different TBI subtypes.
• These molecular differences have implications for TBI pathophysiology.
• Understanding subtype-specific molecular profiles is essential for developing targeted TBI treatments.